Skip to Content

ImmunoCellular Therapeutics Ltd IMUC

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

ImmunoCellular Therapeutics Ltd is seeking to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

Contact
18375 Ventura Boulevard, Suite 381
Tarzana, CA, 91356
T +1 818 996-6807
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jun 30, 2018
Fiscal Year End Dec 31, 2018
Stock Type
Employees 4